Respiratory Disease News and Research

RSS

Nasal photodisinfection therapy for COVID-19 patients may reduce the severity of lower tract respiratory disease

Research on the efficacy of nasal photodisinfection therapy for treating asymptomatic and early stage COVID-19 patients has found that it may reduce the severity of lower tract respiratory disease.

15 Oct 2021

COVID-19 aerosol transmission simulation-based risk analysis for in-person learning

Researchers develop a simulation model to characterize the risks and uncertainties associated with infections from aerosol exposure during in-person classes.

11 Oct 2021

New film campaign encourages people to get free flu vaccine and COVID-19 booster jab

Those eligible for the free flu vaccine and COVID-19 booster jab are being urged to book their appointments as soon as possible in a new film campaign launched today [Friday 8 October] aiming to help people give themselves and their loved ones the best possible protection this winter.

7 Oct 2021

Study shows lower SARS-CoV-2 infection rates in smokers

Coronavirus disease 2019 (COVID-19) primarily infects the lungs, later spreading through the bloodstream. The worst prognoses are mostly seen in ‘at-risk’ groups, such as the immunocompromised, elderly, or those suffering from respiratory conditions.

6 Oct 2021

Detecting early outcomes in COVID-19 patients

A new Nature study aimed to predict clinical data of COVID-19 patients based on clinical outcomes.

21 Sep 2021

Respiratory emissions during labor and delivery can increase the risk of disease transmission

Some medical procedures can put health care workers at higher risk for contracting COVID-19 and other respiratory diseases.

15 Sep 2021

An investigation of SARS-CoV-2 infections among Australian passengers on the Diamond Princess cruise ship

The Diamond Princess Cruise ship left Yokohama (Japan) on 20 January 2020, for a fourteen-day tour with shore excursions in Japan, Hong Kong, Vietnam, and Taiwan. Unfortunately, one of the passengers who complained of mild dry cough was later confirmed to be SARS-CoV-2 positive. In due course, 19% of the passengers were infected with the virus, and thirteen people died.

13 Sep 2021

Seizures as a main manifestation of severe pediatric SARS-CoV-2 infection

A new study aimed to investigate the clinical, demographic, laboratory, neurophysiological, and imaging characteristics of children admitted to the ED with seizures and acute SARS-CoV-2 infection.

8 Sep 2021

Study explores how some men avoid age-related diseases and achieve centenarian status

The largest study of ageing men in the southern hemisphere is exploring why some men have achieved centenarian status and how they have managed to avoid age-related diseases.

7 Sep 2021

Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy

Owlstone Medical today announced the close of its Series D financing round.

From Owlstone Medical Ltd 7 Sep 2021

Post-traumatic stress symptoms in COVID-19 survivors linked with changes to the brain's connectivity

COVID-19 survivors report significantly higher symptoms of post-traumatic stress, and these symptoms are associated with changes to the brain's connectivity, according to a study coauthored by Vince Calhoun, Distinguished Professor of Psychology at Georgia State University and director of the Center for Translational Research in Neuroimaging and Data Science (TReNDS).

27 Aug 2021

COVID-19 pandemic illuminates the importance of airborne transmission of respiratory viruses

SARS-CoV-2, the virus behind today's global coronavirus pandemic, spreads primarily by inhalation of virus-laden aerosols at both short and long ranges -;and a comprehensive new assessment of respiratory viruses finds that many others probably do as well.

27 Aug 2021

Hyfe’s smartphone cough-tracking app used in a groundbreaking epidemiological research

Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, recently announced that their technology is now being incorporated into groundbreaking research in Spain in partnership with the University of Navarra, and involving over 800 participants.

26 Aug 2021

Research finds potential overuse of antibiotics in patients with severe SARS-CoV-2 pneumonia

Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

20 Aug 2021

Research suggests toll-like receptor 4 appears to play role in severe COVID

A group of researchers re-evaluated their previously proposed hypothesis, which stated that the TLR4 activated by the spike glycoprotein S1 domain increases ACE2 expression and, thereby, aids in COVID-19 infection.

16 Aug 2021

Young, healthy adult infected by COVID-19 suffers CNS lymphocytic vasculitis

Although COVID-19 is primarily treated as a respiratory disease, patients often experience neurological problems, such as headaches, anxiety, depression and cognitive issues, which can persist long after other symptoms have resolved.

9 Aug 2021

Cash vouchers provide greater incentive for COVID-19 vaccines than lotteries

A new study focuses on cash vs lottery incentives to increase the acceptance of COVID-19 vaccines among unvaccinated adults in the USA.

30 Jul 2021

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Nanocovax is a protein subunit vaccine that contains the full-length spike stabilized by the addition of two prolines

29 Jul 2021

Kids with allergies less likely to get SARS-CoV-2

Asthma is not associated with worse outcomes among children and adolescents with COVID-19.

28 Jul 2021

Study in France suggests high efficacy of mRNA vaccines against SARS-CoV-2 variants of concern

A nationwide case-control study conducted in France has assessed the efficacy of mRNA-based coronavirus disease 2019 (COVID-19) vaccines against original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants, including B.1.1.7, B.1.351, and P1.

22 Jul 2021